The Treatment of Minimal Residual Disease During Remission in AML
Publisher
Springer Netherlands
Reference42 articles.
1. Weil M, Glidewell OJ, Jacquillat C, et al. 1973. Daunorubicin in the therapy of acute granulocyte leukemia. Cancer Research, 33: 921–928.
2. Young CC, Ozols CF, Myers CE. 1981. The anthracycline antineoplastic drugs. New England Journal of Medicine, 305: 139–153.
3. Ellison RR, Holland JF, Weil M, et al. 1968. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood, 32: 507–523.
4. Southwest Oncology Group. 1974. Cytarabine for acute leukemia in adults: effects of schedule on therapeutic response. Archives of Internal Medicine, 133: 251–259.
5. Gale RP, Foon KA, Cline MJ, et al. 1981. Intensive chemotherapy for acute myelogenous leukemia. Annals of Internal Medicine, 94: 753–757.